Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 701–800 of 1,048

1. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
   Pritam Kumar Panda, N. Arul Murugan, Paritosh Patel, Suresh K. Verma, Wei Luo, Horst‐Günter Rubahn, Yogendra Kumar Mishra, Mrutyunjay Suar, Rajeev Ahuja · 2020 · Science Advances
2. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19
   Qing Ye, Bili Wang, Ting Zhang, Jian Xu, Shiqiang Shang · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
3. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV
   Mihkel Örd, Ilona Faustova, Mart Loog · 2020 · Scientific Reports
4. Airborne Transmission of COVID-19: Aerosol Dispersion, Lung Deposition, and Virus-Receptor Interactions
   Yi Y. Zuo, William E. Uspal, Tao Wei · 2020 · ACS Nano
5. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
   Tzu‐Jing Yang, Pei‐Yu Yu, Yuan‐Chih Chang, Kang-Hao Liang, Hsian-Cheng Tso, Meng‐Ru Ho, Chen Wy, Hsiu-Ting Lin, Han‐Chung Wu, Shang‐Te Danny Hsu · 2021 · Nature Structural & Molecular Biology
6. A CRISPR-based and post-amplification coupled SARS-CoV-2 detection with a portable evanescent wave biosensor
   Yihan Yang, Jinchuan Liu, Xiaohong Zhou · 2021 · Biosensors and Bioelectronics
7. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
   John E. Bowen, Amin Addetia, Ha V. Dang, Cameron Stewart, Jack T Brown, William K. Sharkey, Kaitlin R. Sprouse, Alexandra C. Walls, Ignacio G. Mazzitelli, Jennifer K. Logue et al. · 2022 · Science
8. Impact of the COVID ‐19 Pandemic on Parkinson's Disease and Movement Disorders
   Stella M. Papa, Patrik Brundin, Victor S.C. Fung, Un Jung Kang, David John Burn, Carlo Colosimo, Han‐Lin Chiang, Roy N. Alcalay, Claudia Trenkwalder · 2020 · Movement Disorders
9. Can Zn Be a Critical Element in COVID-19 Treatment?
   Mohammad Tariqur Rahman, Syed Zahir Idid Syed Osman Idid · 2020 · Biological Trace Element Research
10. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
    Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang-Chun David Lee, Xueyong Zhu, Sandhya Bangaru, Jonathan L. Torres, Tom G. Caniels, Philip J. M. Brouwer, Marit J. van Gils et al. · 2020 · Cell Reports
11. Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
    Nicholas E. Ingraham, Abdo Barakat, Ronald A. Reilkoff, Tamara L Bezdicek, Timothy W. Schacker, Jeffrey G. Chipman, Christopher James Tignanelli, Michael A. Puskarich · 2020 · European Respiratory Journal
12. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
    Caio Perez Gomes, Danilo Euclides Fernandes, Fernanda Maria Casimiro da Fonseca, Gustavo Ferreira da Mata, Michelle Tiveron Passos Riguetti, Patrícia Varela, Gianna Mastroianni Kirsztajn, João Bosco Pesquero · 2020 · Frontiers in Cellular and Infection Microbiology
13. TALE: Transformer-based protein function Annotation with joint sequence–Label Embedding
    Yue Cao, Yang Shen · 2021 · Bioinformatics
14. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019
    Bingjie Li, Xin Shane Li, Yaxuan Wang, Yikai Han, Yidi Wang, Chen Wang, Guorui Zhang, Jianjun Jin, Hongxia Jia, Feifei Fan et al. · 2020 · Emerging Microbes & Infections
15. COVID-19 Pandemic: an Overview of epidemiology, pathogenesis, Diagnostics and Potential Vaccines and Therapeutics
    Haneen A. Amawi, Ghina’a Abu Deiab, Alaa A. A. Aljabali, Kamal Dua, Murtaza M. Tambuwala · 2020 · Therapeutic Delivery
16. Novel insights on the pulmonary vascular consequences of COVID-19
    François Potus, Vicky Mai, Marius Lebret, Simon Malenfant, Émilie Breton-Gagnon, Annie Christine Lajoie, Olivier Boucherat, Sébastien Bonnet, Steeve Provencher · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
17. COVID-19, SARS and MERS: A neurological perspective
    Koy Chong Ng Kee Kwong, Puja R. Mehta, Garima Shukla, Arpan R. Mehta · 2020 · Journal of Clinical Neuroscience
18. Neuromechanisms of SARS-CoV-2: A Review
    Marcos Fabio Henriques DosSantos, Sylvie Devalle, Veronica Aran, Daniela Capra, Natália R. Roque, Juliana de Mattos Coelho‐Aguiar, Tânia Cristina Leite de Sampaio e Spohr, Janice Gonçalves Subilhaga, Cláudia Maria Pereira, Isabella D’Andrea Meira et al. · 2020 · Frontiers in Neuroanatomy
19. Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD
    Genwei Zhang, Sebastian J. Pomplun, Alexander R. Loftis, Xuyu Tan, Andrei Loas, Bradley L. Pentelute · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
20. The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
    Esther S. Brielle, Dina Schneidman‐Duhovny, Michal Linial · 2020 · Viruses
21. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
    Donald J. Benton, Antoni G. Wrobel, Chloë Roustan, Annabel Borg, Pengqi Xu, Stephen R. Martin, Peter B. Rosenthal, John James Skehel, Steve J. Gamblin · 2021 · Proceedings of the National Academy of Sciences
22. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
    Lu Qiao, Jia Liu, Shuai Zhao, María Florencia Gómez Castro, Maudry Laurent-Rolle, Jianbo Dong, Xiaojuan Ran, Payal Damani‐Yokota, Hongzhen Tang, Triantafyllia R. Karakousi et al. · 2021 · Immunity
23. Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects
    Sarah Wheeler, Galina V. Shurin, Mary Yost, Adam Anderson, Lisa Pinto, Alan H. Wells, Michael R. Shurin · 2021 · Microbiology Spectrum
24. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
    Jim Baggen, Maarten Jacquemyn, Leentje Persoons, Els Vanstreels, Valerie E. Pye, Antoni G. Wrobel, Valeria Calvaresi, Stephen R. Martin, Chloë Roustan, Nora Cronin et al. · 2023 · Cell
25. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
    Chan, Kui K., Tan, Timothy J. C., Narayanan, Krishna K., Procko, Erik · 2021 · Science Advances
26. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection
    Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Chenjian Gu, Yanling Wu, Bowen Rong, Cheng Li, Siqing Wang, Kun Chen et al. · 2020 · Cell Reports
27. Stabilizing the closed SARS-CoV-2 spike trimer
    Jarek Juraszek, Lucy Rutten, Sven Blokland, Pascale Bouchier, Richard Voorzaat, Tina Ritschel, Mark J. G. Bakkers, Ludovic L. R. Renault, Johannes P. M. Langedijk · 2021 · Nature Communications
28. Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
    Carl Graham, Jeffrey Seow, Isabella Huettner, Hataf Khan, Neophytos Kouphou, Sam Acors, Helena Winstone, Suzanne Pickering, Rui Pedro Galão, Liane Dupont et al. · 2021 · Immunity
29. Antiviral neutralizing antibodies: from in vitro to in vivo activity
    Dennis R. Burton · 2023 · Nature reviews. Immunology
30. The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections
    Farhana Musarrat, Vladimir N. Chouljenko, Achyut Dahal, Rafiq Nabi, Tamara Chouljenko, Seetharama D. S. Jois, Konstantin Gus Kousoulas · 2020 · Journal of Medical Virology
31. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences
    Dorota Maria Szcześniak, Anna Gładka, Błażej Misiak, Agnieszka Cyran, Joanna Rymaszewska · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
32. Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
    Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pažický, Joanna Pieprzyk, Michèle Sorgenfrei, Martin A. Schroer, Andrey Yu. Gruzinov, Cy Michael Jeffries et al. · 2020 · Nature Communications
33. Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
    Jiwan Ge, Ruoke Wang, Bin Ju, Qi Zhang, Jing Sun, Peng Chen, Senyan Zhang, Yuling Tian, Sisi Shan, Lin Cheng et al. · 2021 · Nature Communications
34. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations
    Niraj Kumar Jha, Shreesh Kumar Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh, Shakti Dhar Shukla, Dinesh Kumar Chellappan, Gaurav Gupta, Shanu Bhardwaj, Neeraj Kumar et al. · 2021 · Journal of Molecular Neuroscience
35. S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
    Joshua G. Liang, Danmei Su, Tian‐Zhang Song, Yilan Zeng, Weijin Huang, Jinhua Wu, Rong Xu, Peiwen Luo, Xiaofang Yang, Xiaodong Zhang et al. · 2021 · Nature Communications
36. Adaptive Immune Responses and Immunity to SARS-CoV-2
    Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, Eduard Pavelić, Vilim Molnar, Vid Matišić, Ivana Erceg Ivkošić, Marijo Parčina · 2022 · Frontiers in Immunology
37. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
    Tahir S. Pillay · 2020 · Journal of Clinical Pathology
38. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19
    Pavan Kumar Samudrala, Pramod Kumar, Kamlesh Choudhary, Nagender Thakur, Gaurav Suresh Wadekar, Richa A. Dayaramani, Mukta Agrawal, Amit Alexander · 2020 · European Journal of Pharmacology
39. Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2
    Shao‐Peng Yu, Yuying Zhu, Jiaruo Xu, Guangtao Yao, Pei Zhang, Mengge Wang, Yongfang Zhao, Guo‐Qiang Lin, Hongzhuan Chen, Lili Chen et al. · 2020 · Phytomedicine
40. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site
    Anna Z. Mykytyn, Tim I. Breugem, Samra Riesebosch, Debby Schipper, Petra B. van den Doel, Robbert J. Rottier, Mart Matthias Lamers, Bart L. Haagmans · 2021 · eLife
41. Single-cell transcriptomic atlas of primate cardiopulmonary aging
    Shuai Ma, Shuhui Sun, Jiaming Li, Yanling Fan, Jing Tao Qu, Liang Sun, Si Wang, Yiyuan Zhang, Shanshan Yang, Zunpeng Liu et al. · 2020 · Cell Research
42. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis
    Yanan Chu, Jinxiu Yang, Jiaran Shi, Pingping Zhang, Xingxiang Wang · 2020 · European journal of medical research
43. ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group
    Ruchika Goel, Evan M. Bloch, France Pirenne, Arwa Z. Al‐Riyami, Elizabeth Patricia Crowe, Laetitia Dau, Kevin J. Land, Mary J. Townsend, Jecko V. Thachil, Naomi Rahimi‐Levene et al. · 2021 · Vox Sanguinis
44. A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**
    Anton Schmitz, Anna Weber, Mehtap Bayin, Stefan Breuers, Volkmar Fieberg, Michael Famulok, Günter Mayer · 2021 · Angewandte Chemie International Edition
45. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
    Yasunori Watanabe, Luiza Mendonça, Elizabeth R. Allen, Andrew Howe, Mercede Lee, Joel D. Allen, Himanshi Chawla, David Pulido, Francesca R. Donnellan, H. Dele Davies et al. · 2021 · ACS Central Science
46. The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
    Haolin Liu, Qianqian Zhang, Pengcheng Wei, Zhongzhou Chen, Katja Aviszus, John Jeongseok Yang, Walter Downing, Shelley Peterson, Bo Liang, Bo Liang et al. · 2021 · Cell Research
47. SARS-CoV-2 one year on: evidence for ongoing viral adaptation
    Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, William Barclay · 2021 · Journal of General Virology
48. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
    Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, Mehnaz Kamal, Talha Jawaid, Bapi Gorain, Prashant Kesharwani, Harish Rajak · 2021 · Pharmacological Reports
49. Fomite Transmission, Physicochemical Origin of Virus–Surface Interactions, and Disinfection Strategies for Enveloped Viruses with Applications to SARS-CoV-2
    Nicolas Castaño, Seth C. Cordts, Myra Kurosu Jalil, Kevin S. Zhang, Saisneha Koppaka, Alison Bick, Rajorshi Paul, Sindy K. Y. Tang · 2021 · ACS Omega
50. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation
    Bahaa Jawad, Puja Adhikari, Rudolf Podgornik, W. Y. Ching · 2021 · Journal of Chemical Information and Modeling
51. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
    Gian Paolo Rossi, Viola Sanga, Matthias Barton · 2020 · eLife
52. Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations
    Angelo Spinello, Andrea Saltalamacchia, Alessandra Magistrato · 2020 · The Journal of Physical Chemistry Letters
53. COVID-19: Pulmonary and Extra Pulmonary Manifestations
    Islam Hussam Elrobaa, Karl James New · 2021 · Frontiers in Public Health
54. Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts
    Muh‐Yong Yen, Jonathan R. L. Schwartz, Shey‐Ying Chen, Chwan‐Chuen King, Guang-Yang Yang, Po‐Ren Hsueh · 2020 · Journal of Microbiology Immunology and Infection
55. New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
    Gangqiang Guo, Lele Ye, Kan Pan, Yu Zheng Chen, Dong Xing, Kejing Yan, Zhiyuan Chen, Ning Ding, Wenshu Li, Hong Huang et al. · 2020 · Frontiers in Cell and Developmental Biology
56. Curcumin (a constituent of turmeric): New treatment option against COVID‐19
    Fatemeh Babaei, Marjan Nassiri‐Asl, Hossein Hosseinzadeh · 2020 · Food Science & Nutrition
57. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
    Asif Shajahan, Stephanie A. Archer‐Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiß, Parastoo Azadi · 2020 · Glycobiology
58. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
    Jingchun Song, Gang Wang, Wei Zhang, Yang Zhang, Weiqin Li, Zhou Zhou · 2020 · Military Medical Research
59. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
    Subodh Kumar Samrat, Anil Mathew Tharappel, Zhong Li, Hongmin Li · 2020 · Virus Research
60. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
    Scott Wesley Long, Randall J. Olsen, Paul A. Christensen, David W. Bernard, James J. Davis, Maulik P. Shukla, Marcus Nguyen, Matthew Ojeda Saavedra, Prasanti Yerramilli, Layne Pruitt et al. · 2020 · mBio
61. Antibody-mediated neutralization of SARS-CoV-2
    Henning Gruell, Kanika Vanshylla, Timm Weber, Christopher O. Barnes, Christoph Kreer, Florian Klein · 2022 · Immunity
62. Biomolecular dynamics with machine-learned quantum-mechanical force fields trained on diverse chemical fragments
    Oliver T. Unke, Martin Stöhr, Stefan Ganscha, Thomas Unterthiner, Hartmut Maennel, Sergii Kashubin, Daniel Ahlin, Michael Gastegger, Leonardo Medrano Sandonas, Joshua T. Berryman et al. · 2024 · Science Advances
63. Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis
    Yingyu Chen, Xiao Gong, Lexun Wang, Jiao Guo · 2020 · medRxiv
64. Bibliometric Analysis on COVID-19: A Comparison of Research Between English and Chinese Studies
    Jingchun Fan, Ya Gao, Na Zhao, Runjing Dai, Hailiang Zhang, Xiaoyan Feng, Guoxiu Shi, Jinhui Tian, Che Chen, Brett David Hambly et al. · 2020 · Frontiers in Public Health
65. Flavonoids: A complementary approach to conventional therapy of COVID-19?
    Julia Solnier, Johannes-Paul Fladerer-Grollitsch · 2020 · Phytochemistry Reviews
66. An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor
    Negin Forouzesh, Nikita Mishra · 2021 · Molecules
67. Curcumin as a Potential Treatment for COVID-19
    Bruna Amanda da Cruz Rattis, Simone Gusmão Ramos, Mara Rúbia Nunes Celes · 2021 · Frontiers in Pharmacology
68. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
    Jiandong Huo, Halina Mikolajek, Audrey Le Bas, Jordan J. Clark, Parul Sharma, Anja Kipar, Joshua Dormon, Chelsea S. Norman, Miriam Weckener, Daniel K. Clare et al. · 2021 · Nature Communications
69. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
    Emanuele Andreano, Ida Paciello, Giulia Piccini, Noemi Manganaro, Piero Pileri, Inesa Hyseni, Margherita Leonardi, Elisa Pantano, Valentina Abbiento, Linda Benincasa et al. · 2021 · Nature
70. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
    Dimple Chakravarty, Sujit S. Nair, Nada Hammouda, Parita Ratnani, Yasmine Gharib, Vinayak Gorakhnath Wagaskar, Nihal Mohamed, Dara Lundon, Zachary S. Dovey, Natasha Kyprianou et al. · 2020 · Communications Biology
71. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig
    Yujun Li, Haimin Wang, Xiaojuan Tang, Shisong Fang, Danting Ma, Chengzhi Du, Yifei Wang, Hong Pan, Weitong Yao, Renli Zhang et al. · 2020 · Journal of Virology
72. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2
    Huihui Mou, Brian D. Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo, Shoujiao Peng, Lizhou Zhang, Meredith E. Davis-Gardner, Matthew R. Gardner, Gogce C. Crynen et al. · 2021 · PLoS Pathogens
73. Structural and functional impact by SARS-CoV-2 Omicron spike mutations
    Jun Zhang, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Kumar Gautam, Megan L. Mayer, Sophia Rits‐Volloch et al. · 2022 · Cell Reports
74. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
    Houcemeddine Othman, Zied Bouslama, Jean‐Tristan Brandenburg, Jorge da Rocha, Yosr Hamdi, Kaïs Ghedira, Najet Srairi‐Abid, Scott Hazelhurst · 2020 · Biochemical and Biophysical Research Communications
75. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung
    Hin Chu, Bingjie Hu, Xiner Huang, Yue Chai, Dongyan Zhou, Yixin Wang, Huiping Shuai, Dong Yang, Yuxin Hou, Xi Zhang et al. · 2021 · Nature Communications
76. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
    Amira Mohammed Ali, Hiroshi Kunugi · 2021 · Molecules
77. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
    Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, Griffin D. Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, Hsin-Ping Chiu, Christian S. Stevens, Ariel Esteban Vilardo et al. · 2021 · Nature Communications
78. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades
    Bernadeta Dadonaite, Jack T Brown, Teagan E. McMahon, Ariana Ghez Farrell, Marlin D Figgins, Daniel E. Asarnow, Cameron Stewart, Jimin Lee, Jenni Logue, Trevor Bedford et al. · 2024 · Nature
79. Drug repurposing strategies for COVID-19
    Suranga L Senanayake · 2020 · Future Drug Discovery
80. Modeling the control of COVID-19: impact of policy interventions and meteorological factors
    Jiwei Jia, Jian Ding, Siyu Liu, Guidong Liao, Jingzhi Li, Ben Duan, Guoqing Wang, Ran Zhang · 2020 · Electronic Journal of Differential Equations
81. In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein
    Kiran Gangarapu, Loganathan Karthik, M. S. Shree Devi, Sathiyarajeswaran Parameswaran, K. Kanakavalli, K. M. Kiran Kumar, D. Ramesh Kumar · 2020 · Journal of Ayurveda and Integrative Medicine
82. Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19
    Chung‐Guei Huang, Kuo-Ming Lee, Mei–Jen Hsiao, Shu-Li Yang, Peng-Nien Huang, Yu‐Nong Gong, Tzu-Hsuan Hsieh, Po-Wei Huang, Ya-Jhu Lin, Yi‐Chun Liu et al. · 2020 · Journal of Clinical Microbiology
83. Virus-Mediated Cell-Cell Fusion
    Héloïse Leroy, Mingyu Han, Marie Woottum, Lucie Bracq, Jérôme Bouchet, Maorong Xie, Serge Bénichou · 2020 · International Journal of Molecular Sciences
84. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
    Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, Longfei Ding, Shuai Xia, Xingchen Chen, Mu Liu, Chenjian Gu, Xiaoxia Lü, Yadong Fu et al. · 2022 · Nature Microbiology
85. Two Years into the COVID-19 Pandemic: Lessons Learned
    Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, Jurandy Júnior Ferraz de Magalhães, Justin R. J. Vigar, Abelardo Silva‐Júnior, Alain Kohl et al. · 2022 · ACS Infectious Diseases
86. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
    Wen‐Hsiang Chen, Peter Jay Hotez, María Elena Bottazzi · 2020 · Human Vaccines & Immunotherapeutics
87. The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
    Quinlan, Brian D., Mou, Huihui, Zhang, Lizhou, Guo, Yan, He, Wenhui, Ojha, Amrita, Parcells, Mark S., Luo, Guangxiang, Li, Wenhui, Zhong, Guocai et al. · 2020
88. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein
    Marc C. Johnson, Terri D. Lyddon, Reinier Suarez, Braxton Salcedo, Mary LePique, Maddie Graham, Clifton L. Ricana, Carolyn A. Robinson, Detlef G. Ritter · 2020 · Journal of Virology
89. Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
    Yong Zhang, Wanjun Zhao, Yonghong Mao, Yaohui Chen, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Dan Du, Xiaofeng Lu et al. · 2020 · Molecular & Cellular Proteomics
90. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis
    Lirong Lin, Xiang Wang, Jiangwen Ren, Yan Sun, Rongjie Yu, Kailong Li, Luquan Zheng, Jurong Yang · 2020 · BMJ Open
91. Efforts at COVID-19 Vaccine Development: Challenges and Successes
    Azizul Haque, Anudeep B. Pant · 2020 · Vaccines
92. The Role of Th17 Response in COVID-19
    Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, Robert Flisiak · 2021 · Cells
93. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases
    Chengzhi Yang, Zening Jin · 2020 · JAMA Cardiology
94. Chemistry and Biology of SARS-CoV-2
    Alexander S. S. Dömling, Li Gao · 2020 · Chem
95. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening
    Osmair Vital de Oliveira, Gerd Bruno Rocha, Andrew S. Paluch, Luciano Tavares da Costa · 2020 · Journal of Biomolecular Structure and Dynamics
96. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
    Sina Schwarzkopf, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Andreas Heinold, Falko Markus Heinemann, Laura Thümmler, Christian Temme, Marianne Breyer, Oliver Witzke et al. · 2020 · Emerging infectious diseases
97. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
    Jingwei Bian, Zijian Li · 2020 · Acta Pharmaceutica Sinica B
98. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
    Tianshu Xiao, Jianming Lü, Jun Zhang, Rebecca I. Johnson, Lindsay G. A. McKay, Nadia Storm, Christy L. Lavine, Hanqin Peng, Yongfei Cai, Sophia Rits‐Volloch et al. · 2021 · Nature Structural & Molecular Biology
99. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis
    Nicholas A. Wong, Milton H. Saier · 2021 · International Journal of Molecular Sciences
100. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
     Annachiara Rosa, Valerie E. Pye, Carl Graham, Luke Muir, Jeffrey Seow, Kevin W. Ng, Nicola Cook, Chloe Rees-Spear, Eleanor L. Parker, Mariana Silva dos Santos et al. · 2021 · Science Advances